In line with this, even progenitor-derived MCs from AD patients differ from healthy controls by having enhanced levels of granule mediators and IL-6 responsiveness, indicating a link to the genetic predisposition of atopic disorders [200]. The gene discussed is IL6; the disease is Alzheimer disease.